Dr. Martin Chapman is a leading scientist/entrepreneur in the field of allergy. Dr. Chapman received his PhD in Immunology in 1981 from the Royal Postgraduate Medical School, University of London, U.K. Following postdoctoral fellowships at the London School of Hygiene and Tropical Medicine and at UCLA School of Medicine, Dr. Chapman was appointed to the Faculty at the University of Virginia in 1985 and became a tenured Professor of Medicine and Microbiology. In 2001, he moved from UVA to become President and CEO of InBio (formerly Indoor Biotechnologies Inc.) the company that he founded in 1997.